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The microtubule-associated protein tau isolated from bovine brain was cleaved with CNBr and the 3 largest peptides 
of approx. 21, 19 and 18 kDa were obtained. Dephosphorylation of the CNBr digest of tau with alkaline phosphatase 
changed the electrophoretic mobility of these peptides to 19, 18 and 17 kDa. Amino acid sequencing of the total CNBr 
digest of tau revealed at least 3 sequences, two of which were highly homologous to previously published mouse and 
human tau sequences derived from cDNAs. A third amino acid sequence of 17 residues with heterogeneity at position 
11 showed no homology with the cDNA-derived tau sequences. These studies suggest hat the amino acid sequences of 
mammalian tau predicted from their cDNAs might be incomplete. 
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1. INTRODUCTION 
Microtubule-associated protein tau is a family of 
polypeptides of molecular mass in the range 
55-68 kDa on SDS-PAGE [1,2]. These polypep- 
tides also differ in isoelectric points (6.5-8.0) but 
are closely related to one another in primary struc- 
ture, since they have similar peptide maps and 
amino acid compositions 121. Recent studies [3,4] 
have shown that, depending on the degree of 
phosphorylation, tau polypeptides have different 
electrophoretic mobilities on SDS-PAGE. During 
preparation of this manuscript, the cDNA-derived 
sequences of mouse and human tau became 
available [5,6]. Here, we describe the presence of 
peptides homologous to these derived sequences in 
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bovine brain tau and a unique peptide not present 
in either cDNA-derived sequence. 
2. MATERIALS AND METHODS 
2.1. Isolation of talc 
Tau was isolated from bovine brain, obtained from a local 
slaughterhouse, by the method of Grundke-Iqbal et al. [7]. 
Microtubule proteins obtained by three cycles of assembly- 
disassembly were heat-treated at pH 2.7 and tau from the heat- 
stable MAPS was then extracted in 2.5% perchloric acid [8] and 
dialyzed vs 2.5 mM Tris (pH 7.6). No protein bands other than 
tau were detected on Coomassie blue staining in SDS-PAGE. 
The tau preparation, 0.05 mg protein in 10 ml, was concen- 
trated to 400~1 by evaporation in a Speed Vat (Savant, 
Hicksville, NY), heated with 2 hl of 10% SDS in a boiling water 
bath for 5 min, dialyzed vs several changes of 0.02% SDS for 
24 h, divided into aliquots of 100 pg protein each in Eppendorf 
tubes and again dried in a Speed Vat. 
2.2. Generation of tau peptides by chemical cleavage for amino 
acid sequencing 
Tau in lOO-,ug aliquots was digested with 40 mM CNBr in 
250~1 of 70% formic acid overnight at room temperature in 
darkness, dried in a Speed Vat, resuspended in 50 ~1 Hz0 and 
redried twice as above to remove CNBr and formic acid. The 
digest was taken up in 500~1 derivatizing solution containing 
alcohol, water, triethylamine and PITC (7: 1: 1: 1, v/v), dried 
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and then redried from alcohol, water, triethylamine (2:2: 1, 
v/v) solution in a Speed Vat. In some experiments the CNBr 
digest without drying was diluted with 250 ~1 derivatizing solu- 
tion and dialyzed vs 3 changes (2 h each) of 20 ml per portion 
of derivatizing solution using 3.5 kDa cut-off dialysis bags. 
2.3. Manual Edman degradation and blockage of amino- 
termini with OPA 
Amino acid sequencing of the CNBr digest of tau after PITC 
treatment (see above) revealed several peptides, one of which 
had proline as the second residue. Taking advantage of this 
observation, a CNBr digest of tau was subjected to one manual 
cycle of Edman degradation, followed by blockage with OPA 
of all amino-termini except hat starting with proline. The over- 
night CNBr digest of 100 yg tau (see above) was subjected to a 
2nd digestion with CNBr but for only 3 h to achieve increased 
digestion of the tau polypeptides. The digest was dried twice 
from 50 ,~l water as above. The digest was resuspended by mix- 
ing with a vortex mixer, in 500 ~1 derivatizing solution contain- 
ing alcohol, water, triethylamine and PITC (7 : 1: 1: 1, v/v), 
dried and then redried in 500~1 redrying solution comprising 
alcohol, water and triethylamine (2:2: 1, v/v). Cleavage of 
PITC-labeled amino-terminal residues was then carried out by 
heating the peptide mixture with 250 pl of 100% trifluoroacetic 
acid at 50°C for 5 min. The sample was then dried and redried 
from 50 pl HzO. Blockage of amino-termini with OPA (Pierce, 
Rockford, IL) was then carried out by heating the sample to 
65°C for 10 min with 250 ~1 of a solution prepared by mixing 
20 ,~l of 7% OPA in methanol and mercaptoethanol (5 : 1, v/v) 
solution with 1 ml ethanol, H20, triethylamine (2:2: 1, v/v) 
solution. The sample was dried in a Speed Vat as above and 
subjected to automated gas-phase sequencing. 
2.4. Amino acid analysis and sequencing 
Amino acid analysis was performed using either a Waters 
Pica Tag system (Waters, Millipore Corp., Milford, MA) or a 
Beckman 6300 ninhydrin-based system (Beckman, Palo Alto, 
CA). All hydrolyses were carried out in 6 N HCl, at 110°C for 
24 h. Sequencing was performed on both a Beckman 890 M se- 
quencer and an Applied Biosystems 470A sequencer in the 
presence of polybrene. 
2.5. SDS-PAGE 
Evaluation of the CNBr digestion of tau was carried out on 
5-22% polyacrylamide gradient (8 x 6 x 0.75 cm) gels using 
Laemmli’s Tris-glycine discontinuous buffer system [9]. Tau 
before and after CNBr digestion were run on the same gel. Gels 
were stained with Coomassie blue. 
3. RESULTS 
3.1. Structural relationship between bovine and 
other mammalian tau sequences 
Amino acid analysis of intact bovine tau showed 
good agreement with published data for whole 
porcine tau [2] (table 1). 
Intact bovine tau was subjected to automated N- 
terminal sequencing which resulted in no sequence 
being found. This indicated the presence of a 
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Table 1 
Amino acid composition of tau (mol%) 
Amino Bovine tau Porcine tau 
acid (this study) ]21 
Asp 9.4 9.7 
Thr 7.0 7.6 
Ser 9.7 10.1 
Glu 12.1 10.8 
Pro 9.7 10.4 
Gly 11.6 10.9 
Ala 8.8 7.9 
Val 5.0 5.1 
Met 0.2 1.2 
Be 3.0 2.6 
Leu 5.4 5.5 
Tyr 1.2 1.0 
Phe 1.4 0.9 
LYS 9.6 9.7 
His 2.2 2.6 
Arg 3.9 3.6 
Bovine tau: data obtained from 24 h hydrolysis in 6 N HCl at 
110°C; mean of 4 experiments. Porcine tau: data obtained from 
Cleveland et al. [2] 
blocked amino-terminus. The protein was then 
subjected to CNBr cleavage. The 3 larger 
fragments generated were approx. 21, 19 and 
18 kDa in molecular mass (plots not shown) as 
determined by SDS-PAGE (fig.1, lane 3). After 
dialysis from 3.5 kDa cut-off dialysis bags, the 
mixture was sequenced irectly and resulted in 3 
amino acids at each cycle of Edman degradation. 
Sequences were recovered at the 700 pmol level 
from 100 pg tau digest. A proline residue was iden- 
tified as the second cycle of the mixture. This pro- 
vided the opportunity for reacting the mixture with 
OPA and blocking all a-amino groups. Subse- 
quent sequencing should leave only one peptide 
commencing with proline. To this end, the CNBr 
mixture was subjected to a single cycle of manual 
Edman degradation, treated with OPA, and load- 
ed onto an automated protein sequencer. This pro- 
cedure resulted in a sequence, peptide I, which was 
17 residues in length. Microheterogeneity was 
found at residue 11 where both proline and glycine 
were identified (fig.2). Subtraction of the peptide 
I sequence from data obtained by sequencing the 
CNBr mixture indicated the presence of 2 addi- 
tional sequences, peptides II and III. 
The cDNA-derived sequences of both mouse 
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Fig.1. Electrophoretic patterns of bovine tau, its peptides 
generated by CNBr cleavage and effect of dephosphorylation 
on migration of these peptides. Lanes: 4, tau isolated from 
thrice-cycled calf brain microtubules; 3, same amount of tau as 
lane 4 (10rg) digested with 40 mM CNBr in 70% HCOOH 
overnight; 2, CNBr digest of tau (10 pg) dephosphorylated with 
alkaline phosphatase (1 pg) (upper darkly stained band, marked 
by an arrowhead) overnight at 37°C; 1, molecular mass (in 
kDa) standards (from top to bottom): ovalbumin (43), cy- 
chymotrypsinogen (25.7), &-lactoglobulin (18.4), cytochrome c 
(12.3). Amounts of tau employed,for lanes 2-4 were identical 
(1Opg). Coomassie blue staining of CNBr peptides of tau is 
much weaker than the same amount of the native protein. 
(Met) (Ala) Pro GIY Leu LYS 
1 
Ala Ala Pro GUY 
and human tau have been published [5,6]. They 
show strong homology to each other especially in 
the C-terminal region. Comparison of the two 
bovine sequences II and III with these published 
sequences showed two regions of striking 
homology, both of which coincided with the highly 
conserved C-terminal region. The derived sequence 
of peptide II could be shown to be identical in 17 
of 23 positions when compared to regions 181-203 
of mouse and 192-214 of human tau sequences. 
The derived sequence of peptide III could be 
shown to be identical in 17 of 22 positions to 
regions 319-340 and 330-351 of the published 
mouse and human tau sequences, respectively. The 
sequence of peptide I showed no region of 
homology with either predicted tau sequences nor 
homology to other published sequences in the 
available databanks. A comparison of the 
predicted sequences with those derived from this 
study is shown in fig.3. Subtracting these two se- 
quences from the mixture shows that alanine or 
valine must precede proline in peptide I. Since 
valine is present at this position in peptide III, it 
was decided that alanine would be designated as 
preceding proline. In the case of peptides II and 
III, this type of analysis generates ambiguities at 
positions 2, 4 and 11 where specific assignments 
cannot be made to either polypeptide. 
3.2. Dephosphorylation of bovine tau CNBr 
digest 
Dephosphorylation of the CNBr digest of 
bovine tau changed the electrophoretic mobility of 
the three large peptides on SDS-PAGE (fig. 1). The 
apparent molecular masses of these peptides 
changed from 21, 19 and 18 kDa to 19, 18 and 17 
Pro 




Fig.2. Amino acid sequence of bovine tau peptide I. Sequence 1-17 obtained by automated Edman sequencing of a CNBr digest after 
one cycle of manual Edman degradation and subsequent blocking with OPA. CNBr digestion was performed on 100 pg purified tau 
and the sequence was recovered at the 700 pmol level. Residues in parentheses were deduced from mixed sequence information of the 
total tau CNBr digest (see fig.3). 
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Ser GUY Thr 
Bovine II (Met) Glu Asp Leu Lys Asn Val Gly Gly - Ile Gly 
Mouse Met Pro Asp Leu Lye Asn Val Arg Ser LYS Ile Gly 
181 190 
Human Met Pro Asp Leu LYS Asn Val LYS Ser LYS Ile Gly 
192 201 
Bovine II Ser Thr Glu Asn Leu - - Gln Pro Gly Gly 
Mouse Ser Thr Glu Asn Leu Lys His Gln Pro Gly Gly 
200 203 
Human Ser Thr Glu Asn Leu LYS His Gln Pro Gly Gly 
211 214 
____--_______--____---~~~-----~-----~~_----~_----~ 
Ser Gly Thr 
Bovine III (Met) Val Asp LYS LYS Gln Leu Ala Thr Leu Ala Asp 
Mouse 
Human 
Met Val ASP Ser Pro Gln Leu Ala Thr Leu Ala ASP 
319 330 
Met Val ASP Ser Pro Gln Leu Ala Thr Leu Ala ASP 
330 341 
Bovine III Glu Val - - Ser Leu Ala - .Gln Gly 
Mouse Glu Val Ser Ala Ser Leu Ala LYS Gln Gl Y 
340 
Human Glu Val Ser Ala Ser Leu Ala LYS Gln Gly 
351 
Fig.3. Alignment of bovine tau sequences II and III with the predicted mouse [S] and human [6] tau sequences. Sequences II and III 
were derived by subtracting peptide I from the mixed sequences obtained after CNBr digestion and. generating a ‘best-fit’ alignment 
with the predicted mouse tau sequence. At positions 2, 4 and 11 of peptides II and III specific assignments could not be made due 
to lack of homology. 
(plots not shown). However, the number of pep- 
tides did not change suggesting that bovine tau 
contained 3 large CNBr peptides at least one of 
which could be dephosphorylated. The murine tau 
sequence predicted from its cDNAs has only two 
large peptides of approx. 17 and 15 kDa [5]. 
4. DISCUSSION 
The present study demonstrates (i) the structural 
similarities between two bovine tau peptides and 
the highly conserved C-terminal regions of both 
murine and human tau and (ii) identifies an addi- 
tional peptide not present in either of the cDNA- 
predicted sequences of tau. 
The amino acid composition of bovine tau ob- 
tained here is in close agreement with that of por- 
cine brain tau reported in [2]. The failure of total 
bovine tau to reveal any amino acid sequence in- 
formation by automated Edman degradation in 
this study suggests that tau is amino-terminally 
blocked. Successful isolation of large peptides 
from bovine tau by CNBr digestion in the present 
study revealed multiple sequences which could not 
be ordered with certainty because of the presence 
of approximately equimolar recoveries of the 
amino acids after each cleavage cycle. However, 
the identification of proline at the 2nd cleavage cy- 
cle provided an opportunity to block all amino- 
termini with OPA except that of the sequence 
beginning with proline. A similar approach has 
been used previously using OPA to block the non- 
proline amino-termini of a mixture of peptides 
from &adrenergic receptor [lo]. The subsequent 
tau peptide beginning with proline provided a clear 
17-amino-acid sequence (peptide I). At position 
11, two amino acids, proline and glycine, were 
observed suggesting that microheterogeneity exists 
at this position. Subtraction of the peptide I se- 
quence from the mixed sequences obtained from 
the large CNBr fragments of tau provided a mix- 
ture of 2 sequences. A comparison of these remain- 
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ing mixed sequences with the published tau 
sequences howed that 2 bovine sequences (II and 
III) could be generated which possessed a high 
degree of homology to the murine and human se- 
quences. Peptide I shows no homology with either 
predicted sequences. 
The amino acid sequence data show differences 
between bovine and other mammalian tau 
polypeptides. These differences probably reflect 
both small species differences, i.e. of peptides II 
and III with mouse and human tau, and the 
presence of an additional part of the tau molecule 
not predicted in both cDNA-derived sequences. It 
is of particular interest to note that a portion of 
peptide II shows high homology with residues 
187-203 of the mouse and 198-214 of the human 
sequences. This region is a component of a distinc- 
tive repeating sequence [5] which has been iden- 
tified as the microtubule-binding domain of the 
tau proteins [l 11. 
Tau is known to be a phosphoprotein, different 
degrees of phosphorylation being partly responsi- 
ble for the heterogeneity on SDS-PAGE [3,4]. 
Dephosphorylation of the CNBr digest of bovine 
tau with alkaline phosphatase changed the elec- 
trophoretic mobility of at least one of three large 
peptides observed on SDS-PAGE, but the number 
of the peptide bands was unchanged. The presence 
of these three large CNBr peptides suggests that 
the molecular mass of bovine tau must be con- 
siderably greater than the predicted 35.7 kDa for 
mouse and human tau which should contain only 
two large methionine peptides from the cDNA se- 
quences. The 3 peptides could readily be accom- 
modated by the observed 55-68 kDa size of intact, 
denatured tau. This also suggests that the bovine 
tau protein sequences found in this study represent 
a different form of tau to that proposed previously 
[5,6]. On Western blots, antisera to peptide I label 
all bovine tau polypeptides recognized by other an- 
tibodies to bovine tau but only two of the four 
mouse tau molecular species (Iqbal et al., in 
preparation). The possibility of differential splic- 
ing of the mRNA might account for the differences 
in the amino acid sequences of tau polypeptides. 
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